CYP27A1 (FC = −1.33, p = 0.03) encodes a cholesterol metabolizing enzyme in the brain, which when reduced leads to increased levels of 27-hydroxycholesterol, a feature of AD disease progression [148, 149] and learning and memory impairment [176]. This evidence concerns the gene CYP27A1 and memory impairment.